StudyFinder

Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years

Status: Recruiting

This study will enroll children aged 6 to 12 years who have difficulty in maintaining a healthy weight and see if the medication Vyvanse may help them to reduce their weight.

I'm interested

Sex: Male or Female
Age Group: Up to 18 years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• children 6 to 12 years old
• severe obesity defined as BMI greater than or equal to 1.2 times the 95th percentile
• failed attempt of lifestyle therapy
Exclusion Criteria:

• significant congenital or structural heart disease or arrhythmia
• hypertension
• history of chemical dependency
• Diabetes mellitus (type 1 or 2)
• current or recent ( less than 3 months ago) use of anti-obesity medication(s)
• additional medical or mental health conditions (study staff will review)
Conditions:

Children's Health, Diabetes & Endocrine

Keywords:

healthy weight, Obesity

Study Contact: Cameron Naughton - naug0009@umn.edu
Principal Investigator: Claudia Fox
Phase: EARLY_PHASE1
IRB Number: STUDY00019097
See this study on ClinicalTrials.gov

Back